RECRUITING

Engage Psychosocial Intervention for Cancer Symptoms

Description

The goal of this clinical trial is to test the efficacy a new psychosocial symptom management intervention called ENGAGE for patients with Stage IV breast, prostate, lung, or colorectal cancer. Participants will be randomized to ENGAGE or a Supportive Care intervention. Patient-reported outcomes will be assessed at baseline, 2 months, and 4 months.

Conditions

Advanced Breast CancerAdvanced Prostate CancerAdvanced Lung CancerAdvanced Colorectal CarcinomaAdvanced Colorectal Adenocarcinoma
Talk to us

Related Conditions:

Advanced Breast CancerAdvanced Prostate CancerAdvanced Lung CancerAdvanced Colorectal CarcinomaAdvanced Colorectal Adenocarcinoma

Study Overview

On this page

Study Details

Study overview

The goal of this clinical trial is to test the efficacy a new psychosocial symptom management intervention called ENGAGE for patients with Stage IV breast, prostate, lung, or colorectal cancer. Participants will be randomized to ENGAGE or a Supportive Care intervention. Patient-reported outcomes will be assessed at baseline, 2 months, and 4 months.

Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients With Advanced Cancer

Engage Psychosocial Intervention for Cancer Symptoms

Condition
Advanced Breast Cancer
Intervention / Treatment

-

Contacts and Locations

Durham

Duke Cancer Network, Durham, North Carolina, United States, 27713

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Receiving cancer care at a Duke Cancer Network (DCN) clinic
  • * Oncologist confirmed Stage IV breast, prostate, lung, or colorectal cancer
  • * Worst pain, fatigue, or distress rated at \>/= 3 out of 10 in the past 7 days for at least 2 symptoms
  • * MD Anderson Symptom Inventory (MDASI) Interference with Daily Living Scale average score of \>/= 3 out of 10 in the past 7 days
  • * Eastern Cooperative Oncology Group (ECOG) performance status of 2 or lower
  • * At least 18 years old
  • * Ability to speak and read English
  • * Hearing and vision that allows for successful completion of telehealth sessions
  • * Significant cognitive impairment indicated in medical chart or during telephone screening on a mental status questionnaire
  • * Serious psychiatric condition (e.g., schizophrenia, suicidal intent) that would contraindicate safe study participation
  • * Participation in the last 6 months in Cognitive-Behavioral Therapy or Acceptance and Commitment Therapy for cancer symptom management
  • * Enrollment in hospice at screening

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Duke University,

Study Record Dates

2029-07